-
Massarweh NN,
El-Serag HB.
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Cancer Control.
2017;24(3)
-
Goodman ZD,
Ishak KG,
Langloss JM,
Sesterhenn IA,
Rabin L.
Combined hepatocellular-cholangiocarcinoma.
A histologic and immunohistochemical study.
Cancer.
1985;55:124–135.
-
Allen RA,
Lisa JR.
Combined liver and bile duct carcinoma.
Am J Pathol.
1949;25:647–655.
-
Wang AQ,
Zheng YC,
Du J,
et al.
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
World J Gastroenterol.
2016;22(18):4459-65.
-
Kim,
K.H.,
Lee,
S.G.,
Park,
E.H.
et al.
A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy.
Ann Surg Oncol (2009) 16: 623.
-
Gera S,
Ettel M,
Acosta-Gonzalez G,
Xu R.
Clinical features,
histology,
and histogenesis of combined hepatocellular-cholangiocarcinoma.
World J Hepatol.
2017;9(6):300-309.
-
Vilchez V,
Shah MB,
Daily MF,
et al.
Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.
HPB (Oxford).
2016;18(1):29-34.
-
Fowler KJ,
Sheybani A,
Parker RA 3rd,
Doherty S,
M Brunt E,
Chapman WC,
Menias CO.
Combined Hepatocellular and Cholangiocarcinoma (Biphenotypic) Tumors: Imaging Features and Diagnostic Accuracy of Contrast-Enhanced CT and MRI..
AJR Am J Roentgenol.
2013; 201(2):332-9.
-
Potretzke TA,
Tan BR,
Doyle MB,
Brunt EM,
Heiken JP,
Fowler KJ Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 cases.
American Journal of Roentgenology 2016 207:1,
25-31
-
Groeschl R.T.,
Turaga K.K.,
Gamblin C.
Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
J Surg Oncol.
2013;107:608–612
-
Connell LC,
Harding JJ,
Shia J,
Abou-Alfa GK.
Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Chin Clin Oncol.
2016 Oct;5(5):66.
-
Liver Cancer Study Group of Japan.
Primary liver cancer in Japan.
Clinicopathologic features and results of surgical treatment.
Ann Surg 1990;211:277-87.
-
Kim JH,
Yoon H,
Gi-Young Ko,
Gwon DI et al.
Nonresectable Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Analysis of the Response and Prognostic Factors after Transcatheter Arterial Chemoembolization.
Radiology 2010 255:1,
270-277
-
Rogers JE,
Bolonesi RM,
Rashid A,
et al.
Systemic therapy for unresectable,
mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy.
J Gastrointest Oncol.
2017;8(2):347-351.
-
Maximin S,
Ganeshan DM,
Shanbhogue AK,
et al.
Current update on combined hepatocellular-cholangiocarcinoma.
Eur J Radiol Open.
2014;1:40-8.
Published 2014 Sep 6.
-
Khan R,
Awan S,
Cheow PC,
Tan CK,
Chang PE (2015) Incidental Cholangiocarcinoma is Associated with Poor Outcome in Patients Transplanted for Hepatocellular Carcinoma.
J Gastrointest Dig Sys 5:322.